Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics

Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics

US Patent 7332163 · Granted Feb 19, 2008

Estimated economic value: $177,447,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Aryloxyurea compound and pest control agent2017
Aryloxyurea compound and pest control agent2015
1-heterodiene derivative and pest control agent2015
Cyclic amine compound and acaricide2015
Modified binding molecules comprising connecting peptides2013
Expression and use of anti-CD20 Antibodies2010
Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as the2010
Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as the2010
Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as the2010
Recombinant anti-CD4 antibodies for human therapy2008
Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as the2008
Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as the2008